02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

528A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

The following authors have nothing to disclose: Guo-Xiang Yang, Takashi Tomiyama,<br />

Ying Sun, Weici Zhang, Patrick S. Leung, Xiao-Song He, Sandeep S.<br />

Dhaliwal, M. Eric Gershwin<br />

640<br />

Natural killer cells regulate T cell immunity in primary<br />

biliary cirrhosis<br />

Shinji Shimoda 1 , Minoru Nakamura 2 , M. Eric Gershwin 3 ; 1 Kyushu<br />

University, Fukuoka, Japan; 2 Nagasaki University, Nagasaki,<br />

Japan; 3 UC Davis, Davis, CA<br />

BACKGROUND: Dissection of the multi-lineage response that<br />

leads to biliary epithelial destruction is essential for future therapeutic<br />

efforts. Indeed, a variety of work has already reflected<br />

that there are autoreactive T and B cells that do target biliary<br />

epithelial cells (BEC), but there is also an emerging set of data<br />

that suggests innate immunity is critical not only for the initiation,<br />

but also for a variety of interactions that alter the natural<br />

history of cholangitis. Our previous work has demonstrated that<br />

biliary cell cytotoxity is dependent on the initiation of innate<br />

responses followed by chronic adaptive as well as bystander<br />

mechanisms which are the interactions between natural killer<br />

(NK) cells and BEC. OBJECTIVE: We have taken advantage<br />

of our ability to isolate NK, BEC and endothelial cells from<br />

explanted liver samples, and studied the interactions between<br />

NK cells and BEC and focused on the mechanisms that activated<br />

autoreactive T cells in the presence or absence of antigen<br />

presenting cells (APC) and their dependence on IFN-g as<br />

well as expression of BEC HLA class I and class II molecules.<br />

Explanted liver and spleen from a total of 7 patients included<br />

2 with PBC and 5 with hepatitis C virus infection were used.<br />

There were no significant differences in the results derived from<br />

the liver mononuclear cells or the BEC population from either<br />

PBC or hepatitis C and ultimately all data were combined. This<br />

is consistent with our thesis that the BEC is an innocent victim<br />

as well as the established data that PBC reoccurs following<br />

transplantation. RESULTS: At a high NK/BEC ratio, NK cells<br />

attack autologous BEC in either a PBC-specific nor auto antigen-specific<br />

manner, and as glutathiolation does not occur in<br />

apoptotic BEC, autoantigen PDC-E2 that exists in the mitochondrial<br />

membrane is not degenerated by caspases in PBC, PDC-<br />

E2 from lysed BEC activate autoreactive CD4 positive T cells<br />

in the presence of APC. In contrast, at a low NK/BEC ratio,<br />

BEC were not lysed whereas IFN-g production was induced<br />

from NK cells, which in turn induced expression of HLA class<br />

I and II molecules on BEC and protected them from lysis upon<br />

exposure to autoreactive NK cells. In addition, IFN-g secretion<br />

from NK cells after exposure to autologous BEC enabled autoreactive<br />

CD4 positive T cells to lyse BEC in the presence of<br />

PDC-E2 antigen. CONCLUSION: Our data suggest that NK cell<br />

mediated innate immune responses are critical for the breach<br />

of tolerance at the initial stage of PBC, but also maintained the<br />

cytotoxic effect of autoantigen-specific T cells, which are critical<br />

for disease progression.<br />

Disclosures:<br />

The following authors have nothing to disclose: Shinji Shimoda, Minoru<br />

Nakamura, M. Eric Gershwin<br />

641<br />

Combination Anti-Retroviral Therapy Provides Reduction<br />

in Human Betaretrovirus Load and Durable Biochemical<br />

Responses in Patients with Primary Biliary Cirrhosis<br />

Ellina Lytvyak, Aldo J. Montano-Loza, Lynora Saxinger, Andrew<br />

Mason; University of Alberta, Edmonton, AB, Canada<br />

Purpose/Background: A human betaretrovirus has been characterized<br />

in primary biliary cirrhosis (PBC). Reverse transcriptase<br />

inhibitors lamivudine and zidovudine have shown limited<br />

efficacy. Whereas combination lopinavir/ritonavir (LPRr) and<br />

tenofovir/emticitabine (TDF/FTC) has been reported to be<br />

efficacious in normalizing liver tests (Lancet 2011). Methods:<br />

PBC patients unresponsive to UDCA were randomized into<br />

a crossover study with daily TDF/FTC 300/200mg and LPRr<br />

800/200mg versus placebo for 6 months; followed by an<br />

open label study for a total of 24 months. HBRV DNA was<br />

assessed in PBMC using digital droplet PCR. Results: (A) In the<br />

6 month RCT, a significant reduction in Alk Phos was observed<br />

in patients on TDF/FTC and LPRr (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!